Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study.
The oncologist January 17, 2025 Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip et al. 4 citations
A mindfulness app intervention for patients with metastatic renal cell carcinoma (mRCC) on immunotherapy is feasible and acceptable. Among 50 patients from Brazil and the United States, 96% completed the week 4 assessment, and 75% reported high adherence to daily 20-30 minute app activities. Significant improvements occurred in emotional symptoms, fatigue, and quality of life from baseline to post-intervention. The smartphone-based approach received positive feedback, suggesting it may offer accessible psychosocial support for this population.